Related Experiment Video

Updated: Jun 18, 2026

Murine Fetal Echocardiography
08:04

Murine Fetal Echocardiography

Published on: February 15, 2013

Who should be offered fetal echocardiography? One center's experience with 3965 cases

Reuven Sharony1, Moshe D Fejgin, Tal Biron-Shental

  • 1Genetic Institute, Meir Hospital-Sapir Medical Center, Kfar Saba, Israel. sharony@clalit.org.il

Insights

Fetal echocardiography (FE) is useful for detecting congenital heart disease (CHD). A suspicious level II ultrasound or polyhydramnios significantly increases the likelihood of detecting significant CHD.

Area of Science:

  • Cardiology
  • Prenatal Diagnosis
  • Medical Imaging

Background:

  • Comprehensive fetal heart evaluation often requires fetal echocardiography (FE) by pediatric cardiologists.
  • Economic factors necessitate careful patient selection for FE.
  • Understanding referral indications is crucial for optimizing FE utility.

Purpose of the Study:

  • To assess the diagnostic value of fetal echocardiography (FE) in identifying congenital heart disease (CHD).
  • To analyze the effectiveness of FE based on different referral indications.

Main Methods:

  • Retrospective analysis of 3965 fetal echocardiography (FE) studies conducted between January 2000 and December 2004.
  • Classification of diagnosed cardiac anomalies into significant and non-significant malformations.
  • Calculation of relative risk for detecting CHD based on referral indications: abnormal obstetric scans, maternal/family history, medication use, and maternal request.

Main Results:

  • Overall, 228 (5.8%) cases of congenital heart disease (CHD) were identified.
  • Suspicion of CHD during four-chamber view or level II ultrasound scans was the most frequent referral indication.
  • No correlation was observed between maternal age or gestational age and the detection rate of CHD.

Conclusions:

  • Suspicious findings on level II ultrasound scans are a key indicator for fetal echocardiography (FE).
  • The presence of polyhydramnios is also an important indication for FE in detecting significant congenital heart disease (CHD).
Abstract